The accession code for the named database. A packet of information describing related information about this this target including a database name and an identifier within the database. The database name. Example: GenBank, SWISS-PROT, TrEMBL, PIR, BMRB, PDB The date yyyy-mm-dd. Example: 2003-01-01 Unique identifier for project target. This can be any local identifier used within the project, but it must be unique within the project target list and consistent from across target list updates. Laboratory name. Protein name. Additional text details. Source organism scientific name following the nomenclature of the NCBI Taxonomy database (http://www.ncbi.nih.gov/Taxonomy). Wheeler DL, Chappey C, Lash AE, Leipe DD, Madden TL, Schuler GD, Tatusova TA, Rapp BA (2000). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2000 Jan 1;28(1):10- 4. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Rapp BA, Wheeler DL (2000). GenBank. Nucleic Acids Res 2000 Jan 1;28(1):15-18. Full name. Example: McKeever, Brian M. Postal address. Example: Department of Chemistry and Chemical Biology Rutgers, The State University of New Jersey 610 Taylor Road Piscataway, New Jersey 08854 Electronic mail address. Example: target-help@rcsb.rutgers.edu Organization affliation. Example: MSCG ISO-3166-1 Country code. Examples: United States = US, United Kingdom = GB, Germany = DE Universal resource locator/internet address related to this target. This can be a link to a project site containing more information about this target, or some other related site address. Text description of the role of the individual for which contact information is provided. Contact information related to this target, target collection, or experimental trial. Unique identifier for protocol information. This can be any simple unique identifier (e.g. 1, 2, clone1, purAB, etc). Text description of the protocol. Protocol text descriptions can be divided into as many sections as necessary to provide maximum resuability as they are applied in experimental trials. Additional details related to the protocol. This item may be used to provide small customizations of a standard procedure (e.g. change in temperature, change in volume, etc). An optional short name to identify the protocol section (e.g. HPLC 1, PCR 1, etc). An optional short description of the protocol. A reusable packet of information which must include a unique identifier and a text section describing the protocol. The protocol identifier may be any simple code (e.g. 1, 2, clone1, purAB, etc). The protocol definition may also optionally include a name and a brief description. A reusable list of protocols which must include a unique identifier and a text section describing the protocol. The protocol identifier may be any simple code (e.g. 1, 2, clone1, purAB, etc). The protocol definition may also optionally include a name and a brief description. The protocols defined in this list are referenced in describing the experimental trials attempted on each target. A reference to a predefined protocol description with optional additional details or customization. Protocols are referenced by their id as defined in the protocol list. Protein sequence in IUPAC 1-letter code. The type of sequence specified (i.e. protein, experimental protein, predicted dna, clone, subclone, or predicted protein) Chemical classification of sequence data, either protein or dna. The construct type for this sequence (e.g. full ORF, domain fragment, fragment etc..) A packet of information describing a target sequence. Sequences are described by a one-letter code sequence, by type (i.e. protein, clone, subclone, etc), chemical type (i.e. protein or dna) and construct type (i.e. full orf, domain, domain fragment, etc). In defining a target sequence, it is assumed that the sequence will correspond most closely with the sequence of the ultimate structure determination. A list of sequences related to this target. Identifier for a trial. The target status is defined as one of the following codes: selected cloned expressed soluble purified crystallized diffraction-quality crystals diffraction phasing diffraction-data NMR assigned HSQC crystal structure NMR structure in BMRB in PDB work stopped test target mass spec verified other The status code describing the stage of work at which this trial was terminated. The date that this status state was completed. For instance, the expression of this target was completed on 2004-03-23. Timestamped codes describing critical changes in target status. The status history record includes an enumerated status state, the date corresponding to the beginning of this status state, and an optional completion date and remark. A packet of information describing the details for stopping work on this trial. This includes a code from an enumerated list describing the stage at which the trial was stopped and any additional details. A related target identifier and a description of the relationship. For instance, target TX1001 is a similar sequence in mouse. List of of SG projects/programs with which target is associated. For example: PSI-1 or PSI-2 Program/project name e.g. PSI phase 1 or 2 A name for structural genomics project. Example: PSI Unique identifier for structural genomics project. Example: 1, 2. A packet of information describing the details for stopping work on this target. This includes a code from an enumerated list describing the stage at which the target was stopped and any additional details. The list of related target identifiers and relationships Modifications introduced into the experimental sequence relative to the parent target sequence. A description of differences between the experimental sequence and the parent target sequence. The experimental sequence for this trial. This sequence may contain modifications or or other unanticipated changes relative to the parent target sequence. The list of sequences related to this trial. These may contain deliberate modifications or unanticipated differences from the parent target protein sequence. A list of references to protocols defined in the protocol list that describe the tasks applied in this experimental trial. A description of a set of the sequence tasks employed to produce this target. A trial includes: lab, date, contact information, experimental sequence data, process status data, and references to the protocols used in the trial. A list of protein production trials attempted for this target. This should include both successful and failed trials. A description of a project target including a list of trials used to produce the protein. Format version identifier (i.e. 8, 9, 9.2) The name of site or project contributing protein production and target information (e.g. MCSG, JCSG, CESG, etc.) This is the root element for the site protein production and target list. This includes a format version description, a site identifier, a reusable list of contact information, a reusable list of protocols, a list of project targets. List of specific target groups or categories to which target was assigned. For example, targets can be grouped as "biomedical" targets or "community nominated" targets. Name of target group according to defined enumeration For example: biomedical, community nominated metagenomic membrane protein legacy structural coverage List of experimental measurements associated with a trial. For example: molecular weight, Isoelectiric point, stoichiometry, element content, amino acid modification Describes experimental procedure that is used to perform measurement. For example: X-ray fluorescence gel filtration, mass spec analysis, isoelectiric focusing Describes value of experimental measurement. For example: if <measurementName> is "molecular weight" provide measured weight: 23445 if <measurementName> is isoelectric point provide measured pI: 6.5 if <measurementName> is stiochiometry provide defined ratio: 2:1 If <measurementType> is "element analysis" and element is a metal provide metal name: magnesium, zinc, etc. if <measurementType> is "phosphorylation" provide symbol and position of modified amino acid: S50 Describes name of experimental measurement. For example: molecular weight, isoelectric point, stiochiometry. element analysis phosphorylation methylation Unit of the measurement: Da, KDa, mM, mg, ect. Degree of uncertainty associated with the measurement, which is usually expressed as a standard error of the measurement.